To learn if the new anti-EMMPRIN monoclonal antibody (hMR18-mAb) can reduce EMMPRIN expression levels, we needed to make sure that EMMPRIN is maximally expressed in the co-cultured tumor cells. Here, BSG is linked to neoplasm.